4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 239 | 298 | 1,248 | 500 | 162 |
| Gross Profit | 239 | 298 | 1,248 | 500 | 162 |
| Operating Expenses | 32,375 | 30,404 | 29,967 | 26,995 | 28,588 |
| Operating Income | -32,136 | -30,106 | -28,719 | -26,495 | -28,426 |
| Other Income | 2,520 | 1,424 | 1,340 | 804 | 340 |
| Pre-tax Income | -29,616 | -28,682 | -27,379 | -25,691 | -28,086 |
| Net Income Continuous | -29,616 | -28,682 | -27,379 | -25,691 | -28,086 |
| Net Income | $-29,616 | $-28,682 | $-27,379 | $-25,691 | $-28,086 |
| EPS Basic Total Ops | -0.77 | -0.88 | -0.84 | -0.79 | -0.87 |
| EPS Basic Continuous Ops | -0.77 | -0.88 | -0.84 | -0.79 | -0.87 |
| EPS Diluted Total Ops | -0.77 | -0.88 | -0.84 | -0.79 | -0.87 |
| EPS Diluted Continuous Ops | -0.77 | -0.88 | -0.84 | -0.79 | -0.87 |
| EBITDA(a) | $-31,277 | $-29,472 | $-27,936 | $-25,739 | $-27,491 |